Klinische Daten & Sicherheit

In den folgenden Abschnitten sind die Studien aufgeführt die bis jetzt mit DermACELL durchgeführt wurden. Die genannten Dokumente sowie einzelne Fallstudien sind auf Anfrage erhältlich. Bitte kontaktieren Sie uns bei Interesse: kholenweg@bornmed.com

KLINISCHE BERICHTE MIT DERMACELL BEI CHRONISCHEN WUNDEN
  • Bertasi G. Case study: Treatment of diabetic foot ulcer with human acellular dermal matrix (ADM). (68-20-108)
  • Buchbaum EJ. Case study: Treatment of plantar diabetic ulcer with human acellular dermal matrix (ADM). (68-20-067)
  • Cazzell S. A multicenter, randomized study to assess a sterile, hydrated acellular dermal matrix versus conventional care wound management in subjects with venous stasis ulcers: An interim analysis. (CR-006) SAWC April 29-May 3, 2015.
  • Cazzell S. A multicenter, randomized study to assess a sterile, hydrated acellular dermal matrix versus conventional care wound management in subjects with venous stasis ulcers. (CR-004) SAWC September 26-28, 2015.
  • Chen S-G, Tzeng Y-S, Wang C-H. Case report: Treatment of a severe burn with DermACELL, an acellular dermal matrix. Int J Burn Trauma. 2012;2(2):105-9.
  • Deanesi W, Reitano R, Cogo A. Case report: Treatment of a venous leg ulcer using DermACELL, a human acellular dermal matrix (ADM). (68-20-099)
  • Mulder G. Tissue augmentation and replacement of a heel fat pad with a decellularized sterile human dermal matrix. Wounds. 2012;24(7):185-9.
  • Roussalis J. Novel use of an acellular dermal matrix allograft to treat a chronic scalp wound with bone exposure: A case study. Int J Burn Trauma. 2014;4(2):49-52.
  • Shitrit SB, Ramon Y, Bertasi G. Use of a novel acellular dermal matrix allograft to treat complex trauma wound: A case study. Int J Burn Trauma. 2014;4(2):62-5.
  • Walters J. A multicenter assessment of a sterile, room temperature, acellular dermal matrix versus conventional care wound management in the treatment of diabetic foot ulcers: An interim analysis. (CR-038) SAWC April 29-May 3, 2015.
  • Walters J. A multicenter assessment of a sterile, room temperature, acellular dermal matrix versus conventional care wound management in the treatment of diabetic foot ulcers: An updated interim analysis. (CR-039) SAWC September 26-28, 2015.
  • Walters J, Cazzell S, Pham H, Vayser D, Reyzelman A. Healing rates in a multicenter assessment of a sterile, room temperature, acellular dermal matrix versus conventional care wound management and an active comparator in the treatment of full thickness diabetic foot ulcers. ePlasty. 2016;16(e10).
  • Yonehiro L, Burleson G, Sauer V. Use of new acellular dermal matrix for treatment of non-healing wounds in the lower extremities of patients with diabetes. Wounds. 2013;25(12):340-4.
NICHT MENSCHENBEZOGENE STUDIEN MIT DERMACELL
  • Capito AE, Tholpady SS, Agrawal H, Drake DB, Katz AJ. Evaluation of host tissue integration, revascularization, and cellular infiltration within various dermal substrates. Ann Plast Surg. 2012;68:495-500.
  • Agrawal H, Tholpady SS, Capito AE, Drake DB, Katz AJ (December 2012). Macrophage phenotypes correspond with remodeling outcomes of various acellular dermal matrices. Open Journal of Regenerative Medicine. 2012;1(3):51-9.
  • Moore M, Jones A. Decellularization of human dermis using Matracell technology: Process, preclinical studies, and medical applications. (68-20-029)
  • Rosines E, Lin Q. Analysis of the acellular matrix, growth factors and cytokines present in DermACELL advanced wound management. (68-20-047)
KLINISCHE BERICHTE MIT DERMACELL BEI BRUSTREKONSTRUKTIONEN
  • Bullocks J. DermACELL: A novel and biocompatible acellular dermal matrix in tissue expander and implant-based breast reconstruction. Eur J Plast Surg. 2014; 37(10):529-38.
  • Bullocks J. The New Alternative For Breast Reconstruction Post Mastectomy; Case Study Series Part 1. (68-20-059-01)
  • Bullocks J. The New Alternative For Breast Reconstruction Post Mastectomy; Case Study Series Part 2. (68-20-059-02)
  • Bullocks J. The New Alternative For Breast Reconstruction Post Mastectomy; Case Study Series Part 3. (68-20-059-03)
  • Hanna K, Yu D, LeGallo R, Colen D, Drake D. Matracell processed, sterilized acellular dermal matrix in implant-based breast reconstruction: Clinical and histologic outcomes. Surgical Forum Abstracts. 2013;217(3S):S91.
  • Ortiz JA. Poland’s breast reconstruction with decellularized human dermal allograft. Mil Med. 2014;179(2):e249-52.
  • Park JS, Lee TJ. Comparison of two different acellular dermal matrices sling (AlloDerm, DermACELL) for implant-based immediate breast reconstruction. Milan Breast Cancer Conference June 23-26, 2015.
  • Vashi C. Clinical outcomes for breast cancer patients undergoing mastectomy and reconstruction with the use of DermACELL, a sterile, room temperature acellular dermal matrix. Plastic Surgery International. 2014.
  • Yu D, Hanna K, LeGallo R, Drake D. Comparison of the histological characteristics of ADM capsules to no-ADM breast capsules in ADM-assisted breast reconstruction. Plast Reconstr Surg. 2014;133(3 Suppl):113.
SICHERHEIT
  • Armour AD, Fish JS, Woodhouse KA, Semple JL. A comparison of human and porcine acellularized dermis: Interactions with human fibroblasts in vitro. Plast Reconstr Surg. 2006;117(3):845-56.
  • Bio-Implants Brief. Ensuring the safety of allograft dermal tissue. (68-20-006-02)
  • Moore M. Inactivation of enveloped and non-enveloped viruses on seeded human tissues by gamma irradiation. Cell Tissue Bank. 2012;13(3):401-7.